【券商聚焦】华鑫证券首予H&H国际控股(01112)“买入”评级 指各线品牌产品在市场竞争中均实现一定突破

金吾财讯
Sep 11, 2025

金吾财讯 | 华鑫证券发研指,H&H国际控股(01112)上半年总营收70.19亿元(同增5%),经调整可比EBITDA为11.01亿元(同减3%),经调整可比纯利3.63亿元(同增5%)。该机构指,分业务看,2025H1公司成人营养及护理用品收入同增5%至34.39亿元,主要得益于Swisse创新抗衰品类表现卓越,品牌收入同类比较基准增长39%所致;婴幼儿营养及护理用品收入同增3%至25.01亿元,主要系电商渠道建设及专卖店新手妈妈教育举措有效落地所致,目前产品已顺利完成新国标过渡,其中合生元在超高端婴幼儿配方奶粉市场份额达15.9%,创历史新高;宠物营养及护理用品收入同增10%至10.79亿元,毛利率同增12pct至58.70%,主要系北美渠道合作深化推动Zesty Paws同类比较基准增长13%,同时内地重组Solid Gold后持续推进高端化升级所致,高利产品销售提升亦带动业务盈利水平显著提升。该机构续指,2025H1公司中国内地收入同增9%至49.36亿元,主要系成人营养及护理用品增长强劲叠加渠道快速拓展所致,其中跨境电商渠道收入同增18%,特别是抖音渠道收入同增80%,跃升为重要增长引擎;澳新收入同减18%至8.01亿元,主要系企业代购业务下滑所致;北美收入同增6%至8.62亿元,主要得益于宠物营养品高端化盛行及宠物数量日益增加,亚马逊沃尔玛、PerSmart等主要零售商持续成功;其他区域收入同增17%至4.20亿元,亚洲扩张市场增势亮眼。该机构表示,公司营收恢复增长,毛利明显改善,各线品牌产品在市场竞争中均实现一定突破,线上渠道拓展成效显著。根据2025年半年度业绩公告,该机构预计公司2025-2027年EPS分别为0.79/1.05/1.30元,当前股价对应PE分别为17/13/10倍,首次覆盖,给予“买入”投资评级。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10